Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2006 Jul;98(7):1136–1139.

Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy.

Ferah Yildiz 1, Mine Genc 1, Serap Akyurek 1, Mustafa Cengiz 1, Enis Ozyar 1, Ugur Selek 1, I Lale Atahan 1
PMCID: PMC2569458  PMID: 16895284

Abstract

OBJECTIVE: To evaluate prospectively the efficacy of a single fraction of high-dose radiotherapy in patients with Kaposi's sarcoma. PATIENTS: Between 1994 and 2004, 47 patients with Kaposi's sarcoma were treated at Hacettepe University, Department of Radiation Oncology. Thirteen (28%) patients received chemotherapy before radiotherapy and were referred due to recurrent or progressive disease or intolerance to chemotherapy. All lesions were treated locally with a 2-3-cm safety margin with 4-6-MeV electron beams. Radiotherapy consisted of a single fraction of 8 Gy in the first four years and 6 Gy thereafter. RESULTS: The male:female ratio was 4:1. The median age was 61 years (range 18-87). Eight out of 47 patients (17%) had an underlying immunocompromised state, and one had a previous diagnosis of Hodgkin's disease. Of 203 fields treated, 51 and 152 fields were treated with 8 Gy and 6 Gy, respectively. Overall response rates (RR) at 12 months for 8- and 6 Gy were 93% and 86%, which were not statistically different. However, the difference between complete RRs at 12 months (93% and 60% for 8 Gy and 6 Gy respectively) was significant (p<0.0001). Progression-free survival and reirradiation rates were not significantly different. Side effects were tolerable in all but three patients with grade 2-3 fibrosis and edema. CONCLUSION: Radiotherapy is an effective mode of treatment for Kaposi's sarcoma, and a single dose of 8 Gy is more effective in terms of complete RR compared to 6 Gy, though overall response and progression-free survival rates were similar.

Full text

PDF
1136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antman K., Chang Y. Kaposi's sarcoma. N Engl J Med. 2000 Apr 6;342(14):1027–1038. doi: 10.1056/NEJM200004063421407. [DOI] [PubMed] [Google Scholar]
  2. Berson A. M., Quivey J. M., Harris J. W., Wara W. M. Radiation therapy for AIDS-related Kaposi's Sarcoma. Int J Radiat Oncol Biol Phys. 1990 Sep;19(3):569–575. doi: 10.1016/0360-3016(90)90482-y. [DOI] [PubMed] [Google Scholar]
  3. Brambilla L., Labianca R., Ferrucci S. M., Taglioni M., Boneschi V. Treatment of classical Kaposi's sarcoma with gemcitabine. Dermatology. 2001;202(2):119–122. doi: 10.1159/000051610. [DOI] [PubMed] [Google Scholar]
  4. Brenner B., Rakowsky E., Katz A., Gutman H., Sulkes A., Schacter J., Fenig E. Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines. Int J Oncol. 1999 Jun;14(6):1097–1102. doi: 10.3892/ijo.14.6.1097. [DOI] [PubMed] [Google Scholar]
  5. Chang L. F., Reddy S., Shidnia H. Comparison of radiation therapy of classic and epidemic Kaposi's sarcoma. Am J Clin Oncol. 1992 Jun;15(3):200–206. doi: 10.1097/00000421-199206000-00004. [DOI] [PubMed] [Google Scholar]
  6. Cooper J. S., Steinfeld A. D., Lerch I. Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):419–422. doi: 10.1016/0360-3016(91)90051-5. [DOI] [PubMed] [Google Scholar]
  7. Finesmith T. H., Shrum J. P. Kaposi's sarcoma. Int J Dermatol. 1994 Nov;33(11):755–762. doi: 10.1111/j.1365-4362.1994.tb00983.x. [DOI] [PubMed] [Google Scholar]
  8. Friedman-Birnbaum R., Weltfriend S., Katz I. Kaposi's sarcoma: retrospective study of 67 cases with the classical form. Dermatologica. 1990;180(1):13–17. doi: 10.1159/000247978. [DOI] [PubMed] [Google Scholar]
  9. Friedman-Kien A. E., Saltzman B. R. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1237–1250. doi: 10.1016/0190-9622(90)70169-i. [DOI] [PubMed] [Google Scholar]
  10. Hamilton C. R., Cummings B. J., Harwood A. R. Radiotherapy of Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):1931–1935. doi: 10.1016/0360-3016(86)90127-6. [DOI] [PubMed] [Google Scholar]
  11. Harrison M., Harrington K. J., Tomlinson D. R., Stewart J. S. Response and cosmetic outcome of two fractionation regimens for AIDS-related Kaposi's sarcoma. Radiother Oncol. 1998 Jan;46(1):23–28. doi: 10.1016/s0167-8140(97)00141-2. [DOI] [PubMed] [Google Scholar]
  12. Hill D. R. The role of radiotherapy for epidemic Kaposi's sarcoma. Semin Oncol. 1987 Jun;14(2 Suppl 3):19–22. [PubMed] [Google Scholar]
  13. Holecek M. J., Harwood A. R. Radiotherapy of Kaposi's sarcoma. Cancer. 1978 May;41(5):1733–1738. doi: 10.1002/1097-0142(197805)41:5<1733::aid-cncr2820410513>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  14. Kigula-Mugambe Joseph B., Kavuma Awusi. Epidemic and endemic Kaposi's sarcoma: a comparison of outcomes and survival after radiotherapy. Radiother Oncol. 2005 Jul;76(1):59–62. doi: 10.1016/j.radonc.2005.06.008. [DOI] [PubMed] [Google Scholar]
  15. Lo T. C., Salzman F. A., Smedal M. I., Wright K. A. Radiotherapy for Kaposi's sarcoma. Cancer. 1980 Feb 15;45(4):684–687. doi: 10.1002/1097-0142(19800215)45:4<684::aid-cncr2820450411>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  16. Nisce L. Z., Safai B., Poussin-Rosillo H. Once weekly total and subtotal skin electron beam therapy for Kaposi's sarcoma. Cancer. 1981 Feb 15;47(4):640–644. doi: 10.1002/1097-0142(19810215)47:4<640::aid-cncr2820470403>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  17. Olweny Charles L. M., Borok Margaret, Gudza Ivy, Clinch Jennifer, Cheang Mary, Kiire Clem F., Levy Lorraine, Otim-Oyet David, Nyamasve Joseph, Schipper Harvey. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial. Int J Cancer. 2005 Feb 10;113(4):632–639. doi: 10.1002/ijc.20606. [DOI] [PubMed] [Google Scholar]
  18. Piccinno R., Caccialanza M., Cusini M. Role of radiotherapy in the treatment of epidemic Kaposi's sarcoma: experience with sixty-five cases. J Am Acad Dermatol. 1995 Jun;32(6):1000–1003. doi: 10.1016/0190-9622(95)91339-4. [DOI] [PubMed] [Google Scholar]
  19. Piedbois P., Frikha H., Martin L., Levy E., Haddad E., Le Bourgeois J. P. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1207–1211. doi: 10.1016/0360-3016(94)90330-1. [DOI] [PubMed] [Google Scholar]
  20. Sarid R., Wiezorek J. S., Moore P. S., Chang Y. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol. 1999 Feb;73(2):1438–1446. doi: 10.1128/jvi.73.2.1438-1446.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stein M. E., Kantor A., Spencer D., Bezwoda W. R. Classical Kaposi's sarcoma in Caucasians in Africa--experience at the Johannesburg Hospital (1978-1992). Dermatology. 1994;188(3):182–187. doi: 10.1159/000247135. [DOI] [PubMed] [Google Scholar]
  22. Stelzer K. J., Griffin T. W. A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1057–1061. doi: 10.1016/0360-3016(93)90523-x. [DOI] [PubMed] [Google Scholar]
  23. Tombolini V., Osti M. F., Bonanni A., Valeriani M., Iacari W., Donato V., Enrici R. M. Radiotherapy in classic Kaposi's sarcoma (CKS): experience of the Institute of Radiology of University "La Sapienza" of Rome. Anticancer Res. 1999 Sep-Oct;19(5C):4539–4544. [PubMed] [Google Scholar]
  24. Wahman A., Melnick S. L., Rhame F. S., Potter J. D. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma. Epidemiol Rev. 1991;13:178–199. doi: 10.1093/oxfordjournals.epirev.a036068. [DOI] [PubMed] [Google Scholar]
  25. Weshler Z., Loewinger E., Loewenthal E., Levinson R., Fuks Z. Megavoltage radiotherapy using water bolus in the treatment of Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):2029–2032. doi: 10.1016/0360-3016(86)90142-2. [DOI] [PubMed] [Google Scholar]
  26. Yildiz F., Ozyar E., Uzal D., Sahin S., Atahan I. L. Kaposi's sarcoma: the efficacy of a single fraction of 800 cGy. Dermatology. 1997;195(2):142–144. doi: 10.1159/000245717. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES